Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Olsson

Showing results (111-120 of 216) with videos related to

Pageof 22
Sort By:
Thrombosis and Haemostasis|June 28, 1990
The use of a commercial ELISA for assay of thrombin-antithrombin complexes in purified systemsG Elgue, B Pasche, M Blombäck, et al.
Bioconjugate Chemistry|September 1, 1996
Development and in vitro studies of epidermal growth factor-dextran conjugates for boron neutron capture therapyL Gedda, P Olsson, J Pontén, et al.
Thrombosis Research|November 15, 1983
Effect of glycosaminoglycans and antithrombin III on uptake and inhibition of thrombin by the vascular wallM Dryjski, R Larsson, P Olsson, et al.
Acta Oto-Laryngologica|November 1, 1992
Efficacy of a topical nasal decongestant in different formulations: the effect of viscosityC J Johansson, T Carlson, P Olsson, et al.
Thrombosis Research|January 1, 1979
Platelet and plasma coagulation compatibility of heparinized and sulphated surfacesR Larsson, J C Eriksson, H Lagergren, et al.
International Journal of Sports Medicine|March 25, 1999
Carbohydrate intake and multiple sprint sports: with special reference to football (soccer)P D Balsom, K Wood, P Olsson, et al.
Journal of Biomaterials Science. Polymer Edition|March 27, 2001
On the blood compatibility of end-point immobilized heparinP Olsson, J Sanchez, T E Mollnes, et al.
Medical Device Technology|February 7, 1995
Surface modification with functionally active heparinJ Riesenfeld, P Olsson, J Sanchez, et al.
Artificial Organs|December 1, 1991
Binding of antithrombin to immobilized heparin under varying flow conditionsB Pasche, G Elgue, P Olsson, et al.
Clinical Pharmacology and Therapeutics|September 1, 1992
Intravenous nicotine retards transdermal absorption of nicotine: evidence of blood flow--limited percutaneous absorptionN L Benowitz, P Jacob, P Olsson, et al.
Pageof 22

Showing results (111-120 of 216) with videos related to

Sort By:
Pageof 22
Thrombosis and Haemostasis|June 28, 1990
The use of a commercial ELISA for assay of thrombin-antithrombin complexes in purified systemsG Elgue, B Pasche, M Blombäck, et al.
Bioconjugate Chemistry|September 1, 1996
Development and in vitro studies of epidermal growth factor-dextran conjugates for boron neutron capture therapyL Gedda, P Olsson, J Pontén, et al.
Thrombosis Research|November 15, 1983
Effect of glycosaminoglycans and antithrombin III on uptake and inhibition of thrombin by the vascular wallM Dryjski, R Larsson, P Olsson, et al.
Acta Oto-Laryngologica|November 1, 1992
Efficacy of a topical nasal decongestant in different formulations: the effect of viscosityC J Johansson, T Carlson, P Olsson, et al.
Thrombosis Research|January 1, 1979
Platelet and plasma coagulation compatibility of heparinized and sulphated surfacesR Larsson, J C Eriksson, H Lagergren, et al.
International Journal of Sports Medicine|March 25, 1999
Carbohydrate intake and multiple sprint sports: with special reference to football (soccer)P D Balsom, K Wood, P Olsson, et al.
Journal of Biomaterials Science. Polymer Edition|March 27, 2001
On the blood compatibility of end-point immobilized heparinP Olsson, J Sanchez, T E Mollnes, et al.
Medical Device Technology|February 7, 1995
Surface modification with functionally active heparinJ Riesenfeld, P Olsson, J Sanchez, et al.
Artificial Organs|December 1, 1991
Binding of antithrombin to immobilized heparin under varying flow conditionsB Pasche, G Elgue, P Olsson, et al.
Clinical Pharmacology and Therapeutics|September 1, 1992
Intravenous nicotine retards transdermal absorption of nicotine: evidence of blood flow--limited percutaneous absorptionN L Benowitz, P Jacob, P Olsson, et al.
Pageof 22